Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

5.45
+0.30005.83%
Post-market: 5.450.00000.00%19:58 EDT
Volume:1.34M
Turnover:7.20M
Market Cap:753.40M
PE:-1.29
High:5.48
Open:5.25
Low:5.18
Close:5.15
Loading ...

CrowdStrike Fuels Partner Growth and Profitability with Expanded Accelerate Partner Program

Business Wire
·
11 Mar

Vir Biotechnology Is Maintained at Overweight by Barclays

Dow Jones
·
01 Mar

Vir Biotechnology Price Target Maintained With a $110.00/Share by HC Wainwright & Co.

Dow Jones
·
28 Feb

Barclays Remains a Buy on Vir Biotechnology (VIR)

TIPRANKS
·
28 Feb

Stock Track | Vir Biotechnology Plummets 9.46% as Key Pipeline Programs Remain Early-Stage

Stock Track
·
28 Feb

Q4 2024 Vir Biotechnology Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Feb

Stock Track | Vir Biotechnology Soars 5.98% on Strong Q4 Results and Promising Outlook

Stock Track
·
27 Feb

Vir Biotechnology Price Target Maintained With a $19.00/Share by Needham

Dow Jones
·
27 Feb

Vir Biotechnology Inc (VIR) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...

GuruFocus.com
·
27 Feb

Vir Biotechnology Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
27 Feb

Vir Biotechnology reports Q4 EPS (76c), consensus (87c)

TIPRANKS
·
27 Feb

Vir Biotechnology Q4 GAAP EPS $(0.76) Beats $(0.87) Estimate, Sales $12.37M Beat $8.14M Estimate

Benzinga
·
27 Feb

BRIEF-Vir Biotechnology Q4 Cash & Investments USD 1,100 Million

Reuters
·
27 Feb

Vir Biotechnology Inc: Qtrly Shr Loss $0.76

THOMSON REUTERS
·
27 Feb

Vir Biotechnology Inc: Expects Its Cash, Cash Equivalents and Investments to Fund Its Operations Into Mid-2027.

THOMSON REUTERS
·
27 Feb

Vir Biotechnology Q4 Cash & Investments USD 1,100 Million

THOMSON REUTERS
·
27 Feb

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Business Wire
·
27 Feb

Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference

Business Wire
·
20 Feb

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Irhythm Technologies (IRTC), Vir Biotechnology (VIR) and Biogen (BIIB)

TIPRANKS
·
13 Feb